Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (260)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mutation
21
2022
1293
1.800
 Why?
Multiple Myeloma
38
2023
2910
1.770
 Why?
High-Throughput Nucleotide Sequencing
5
2021
169
1.060
 Why?
Translocation, Genetic
14
2021
264
1.010
 Why?
Oncogenes
2
2018
58
0.760
 Why?
Biliary Tract Neoplasms
1
2018
8
0.620
 Why?
Gene Expression Profiling
14
2022
1031
0.610
 Why?
Cholangiocarcinoma
1
2018
27
0.610
 Why?
Genomics
8
2022
282
0.570
 Why?
Proto-Oncogene Proteins B-raf
3
2022
79
0.540
 Why?
Gene Expression Regulation, Neoplastic
11
2022
829
0.540
 Why?
Prognosis
15
2021
1952
0.440
 Why?
Brain Neoplasms
3
2023
286
0.420
 Why?
Gene Dosage
5
2020
78
0.410
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
987
0.400
 Why?
Genetic Predisposition to Disease
5
2018
510
0.390
 Why?
Plasma Cells
4
2021
223
0.390
 Why?
Genome, Human
4
2021
111
0.370
 Why?
Evolution, Molecular
2
2021
99
0.370
 Why?
Liver Neoplasms
3
2022
332
0.360
 Why?
Humans
51
2023
49827
0.360
 Why?
DNA Mutational Analysis
7
2020
175
0.350
 Why?
Thalidomide
5
2019
374
0.340
 Why?
DNA Copy Number Variations
4
2021
110
0.340
 Why?
In Situ Hybridization, Fluorescence
11
2023
252
0.330
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
103
0.310
 Why?
Software
2
2021
273
0.310
 Why?
Neoplasm Recurrence, Local
3
2021
618
0.290
 Why?
Carcinoma, Hepatocellular
2
2022
194
0.290
 Why?
Chromosome Aberrations
6
2022
298
0.280
 Why?
Polymorphism, Single Nucleotide
3
2018
485
0.280
 Why?
Epigenesis, Genetic
4
2018
373
0.260
 Why?
Clonal Evolution
2
2019
56
0.260
 Why?
Chromosomes, Human, Pair 1
2
2019
93
0.260
 Why?
Immunoglobulin Heavy Chains
3
2014
41
0.260
 Why?
Neoplasm Proteins
3
2017
323
0.250
 Why?
Disease Progression
8
2021
822
0.240
 Why?
Gene Regulatory Networks
2
2022
107
0.230
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
23
0.220
 Why?
Male
25
2021
25093
0.220
 Why?
Polycomb Repressive Complex 2
2
2021
47
0.220
 Why?
Chromosomes, Human, Pair 14
5
2014
75
0.220
 Why?
Female
26
2021
26329
0.210
 Why?
Central Nervous System Neoplasms
1
2023
63
0.210
 Why?
Exome
4
2017
46
0.210
 Why?
STAT2 Transcription Factor
1
2021
7
0.200
 Why?
Middle Aged
17
2021
11997
0.200
 Why?
Germ-Line Mutation
2
2021
61
0.200
 Why?
Aged
15
2021
9272
0.200
 Why?
STAT1 Transcription Factor
1
2021
26
0.200
 Why?
Hematologic Neoplasms
1
2023
99
0.200
 Why?
Li-Fraumeni Syndrome
1
2021
13
0.200
 Why?
Genome-Wide Association Study
3
2018
166
0.200
 Why?
Japan
2
2018
26
0.190
 Why?
Aged, 80 and over
9
2021
3125
0.180
 Why?
Gene Frequency
2
2017
94
0.180
 Why?
Ecosystem
1
2021
62
0.180
 Why?
Cell Cycle
1
2021
232
0.180
 Why?
Neoplasms
2
2020
1233
0.180
 Why?
Glioblastoma
1
2021
91
0.180
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
 Why?
Leukemia, Plasma Cell
1
2020
33
0.180
 Why?
DNA Methylation
3
2016
548
0.180
 Why?
Chromosomal Instability
1
2019
16
0.170
 Why?
Genes, myc
1
2019
40
0.170
 Why?
Chromosomes, Human, Pair 4
3
2014
31
0.160
 Why?
Diploidy
2
2017
26
0.160
 Why?
Cell Survival
2
2018
598
0.160
 Why?
Chromosomes, Human, Pair 11
3
2014
54
0.160
 Why?
Adult
13
2021
13160
0.160
 Why?
INDEL Mutation
1
2018
4
0.160
 Why?
Genes, Tumor Suppressor
2
2021
73
0.160
 Why?
Mutagenesis
1
2018
60
0.160
 Why?
Italy
1
2018
26
0.160
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.160
 Why?
Transcriptional Elongation Factors
1
2017
18
0.150
 Why?
Chromosomes, Human, Pair 5
1
2017
17
0.150
 Why?
Histone-Lysine N-Methyltransferase
2
2016
56
0.150
 Why?
Transcriptome
4
2021
313
0.150
 Why?
Enhancer Elements, Genetic
1
2017
61
0.150
 Why?
Reproducibility of Results
1
2021
1188
0.150
 Why?
Chromosomes, Human
1
2017
41
0.150
 Why?
Melanoma
1
2020
284
0.140
 Why?
Hepatocytes
1
2018
181
0.140
 Why?
Immunologic Factors
1
2017
114
0.140
 Why?
B-Lymphocytes
2
2016
170
0.140
 Why?
Neoplasms, Multiple Primary
1
2016
44
0.140
 Why?
Neoplasm Metastasis
1
2016
231
0.130
 Why?
Melphalan
2
2013
174
0.130
 Why?
Oligodendroglioma
1
2015
6
0.130
 Why?
Sequence Analysis, DNA
2
2016
237
0.130
 Why?
Endoribonucleases
1
2015
15
0.130
 Why?
ras Proteins
1
2015
64
0.130
 Why?
Survival Rate
4
2020
905
0.120
 Why?
Skin Neoplasms
1
2020
487
0.120
 Why?
Endoplasmic Reticulum Stress
1
2015
36
0.120
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
40
0.120
 Why?
Survival Analysis
5
2015
659
0.120
 Why?
SMN Complex Proteins
1
2014
4
0.120
 Why?
Signal Transduction
5
2022
1617
0.120
 Why?
RNA Processing, Post-Transcriptional
1
2014
24
0.120
 Why?
Mutation Rate
3
2021
36
0.120
 Why?
Cyclin D
1
2013
18
0.120
 Why?
Chromosome Deletion
2
2011
141
0.120
 Why?
Transcription Factors
2
2015
563
0.120
 Why?
Kaplan-Meier Estimate
4
2018
469
0.120
 Why?
Genes, erbB-1
1
2013
8
0.110
 Why?
RNA, Neoplasm
1
2013
44
0.110
 Why?
Nerve Tissue Proteins
1
2015
193
0.110
 Why?
Cell Line, Tumor
4
2022
1402
0.110
 Why?
Chromosome Breakage
1
2013
16
0.110
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.110
 Why?
Germinal Center
1
2013
23
0.110
 Why?
Repressor Proteins
1
2014
151
0.110
 Why?
RNA Splicing
3
2021
37
0.110
 Why?
Genetic Heterogeneity
1
2012
18
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
177
0.100
 Why?
DNA-Binding Proteins
1
2015
436
0.100
 Why?
Acetyltransferases
1
2011
20
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
27
0.100
 Why?
RNA, Messenger
1
2015
1105
0.100
 Why?
Chromosomes, Human, Pair 17
1
2011
36
0.100
 Why?
Antineoplastic Agents
3
2018
1172
0.100
 Why?
DNA, Neoplasm
3
2018
147
0.100
 Why?
Cell Proliferation
3
2022
1007
0.100
 Why?
Multivariate Analysis
3
2021
585
0.090
 Why?
TOR Serine-Threonine Kinases
1
2010
77
0.090
 Why?
Tumor Suppressor Protein p53
1
2011
202
0.090
 Why?
Phenotype
3
2022
727
0.090
 Why?
Remission Induction
2
2021
207
0.090
 Why?
Clone Cells
2
2021
74
0.090
 Why?
MicroRNAs
1
2013
354
0.080
 Why?
Alleles
2
2021
251
0.080
 Why?
DNA
1
2012
545
0.080
 Why?
Transcriptional Activation
2
2021
122
0.080
 Why?
Spliceosomes
2
2021
10
0.080
 Why?
Follow-Up Studies
3
2020
2179
0.070
 Why?
Genomic Instability
2
2018
92
0.070
 Why?
Epigenomics
2
2017
67
0.070
 Why?
Risk Factors
3
2021
3619
0.070
 Why?
Loss of Heterozygosity
2
2018
77
0.060
 Why?
Disease-Free Survival
2
2019
457
0.060
 Why?
Treatment Outcome
4
2019
5138
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.060
 Why?
Protein Binding
2
2017
660
0.060
 Why?
Liver
2
2022
1109
0.060
 Why?
Genotype
2
2017
538
0.060
 Why?
Dexamethasone
2
2019
429
0.060
 Why?
Histones
2
2016
315
0.050
 Why?
Proportional Hazards Models
2
2015
406
0.050
 Why?
Janus Kinase 1
1
2021
17
0.050
 Why?
Janus Kinase 2
1
2021
26
0.050
 Why?
Nitriles
1
2021
54
0.050
 Why?
Gene Rearrangement
1
2022
74
0.050
 Why?
Organoids
1
2021
39
0.050
 Why?
Syndecan-1
1
2021
72
0.050
 Why?
Microarray Analysis
2
2012
73
0.050
 Why?
Biomarkers, Pharmacological
2
2011
25
0.050
 Why?
Chromosome Mapping
2
2011
160
0.050
 Why?
Polymerase Chain Reaction
2
2013
455
0.050
 Why?
Pyrazoles
1
2021
113
0.050
 Why?
Cell Movement
1
2022
247
0.050
 Why?
Cell Line
2
2015
1002
0.050
 Why?
Alternative Splicing
1
2021
57
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.050
 Why?
Pyrimidines
1
2021
191
0.050
 Why?
Phosphoproteins
1
2021
113
0.050
 Why?
Gene Expression
2
2013
608
0.040
 Why?
Lymphoma, Follicular
1
2020
27
0.040
 Why?
Prospective Studies
2
2016
2344
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Recurrence
1
2021
651
0.040
 Why?
Young Adult
2
2021
3936
0.040
 Why?
Maintenance Chemotherapy
1
2019
49
0.040
 Why?
Syndrome
1
2019
234
0.040
 Why?
Transcription Elongation, Genetic
1
2017
2
0.040
 Why?
Physical Chromosome Mapping
1
2017
8
0.040
 Why?
Genetic Drift
1
2017
3
0.040
 Why?
Gene Knockdown Techniques
1
2018
106
0.040
 Why?
Caspases
1
2018
104
0.040
 Why?
Unfolded Protein Response
1
2017
32
0.040
 Why?
Genetic Loci
1
2017
49
0.040
 Why?
Xenograft Model Antitumor Assays
1
2018
210
0.040
 Why?
Molecular Targeted Therapy
1
2018
119
0.040
 Why?
Mitosis
1
2017
92
0.040
 Why?
Genetic Association Studies
1
2017
116
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Algorithms
1
2020
616
0.030
 Why?
Virus Integration
1
2016
9
0.030
 Why?
Comparative Genomic Hybridization
1
2016
47
0.030
 Why?
Risk
1
2017
320
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
41
0.030
 Why?
Computational Biology
1
2018
214
0.030
 Why?
Tumor Microenvironment
1
2017
210
0.030
 Why?
Nuclear Proteins
1
2017
243
0.030
 Why?
Immunosuppressive Agents
1
2017
220
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
17
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
Antibodies, Monoclonal
1
2019
458
0.030
 Why?
RNA Stability
1
2015
24
0.030
 Why?
Patient Selection
1
2016
251
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
50
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
19
0.030
 Why?
Amino Acid Sequence
1
2016
587
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
10
0.030
 Why?
Cytogenetic Analysis
1
2014
82
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Flow Cytometry
1
2017
470
0.030
 Why?
Single-Cell Analysis
1
2014
55
0.030
 Why?
Introns
1
2014
49
0.030
 Why?
Time Factors
1
2021
2912
0.030
 Why?
Methylation
1
2014
123
0.030
 Why?
Protein Isoforms
1
2014
119
0.030
 Why?
Down-Regulation
1
2015
349
0.030
 Why?
Base Sequence
1
2015
650
0.030
 Why?
High-Throughput Screening Assays
1
2013
37
0.030
 Why?
Protein Structure, Tertiary
1
2014
253
0.030
 Why?
HeLa Cells
1
2014
251
0.030
 Why?
Molecular Sequence Data
1
2015
797
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.030
 Why?
Karyotyping
1
2013
83
0.030
 Why?
Azacitidine
1
2013
34
0.030
 Why?
Transforming Growth Factor beta1
1
2013
59
0.030
 Why?
Early Detection of Cancer
1
2014
165
0.030
 Why?
Homologous Recombination
1
2013
39
0.030
 Why?
Mass Spectrometry
1
2014
306
0.030
 Why?
Disease Models, Animal
1
2018
1451
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Tumor Suppressor Proteins
1
2013
127
0.030
 Why?
Apoptosis
1
2018
1100
0.030
 Why?
Gene Library
1
2012
44
0.030
 Why?
Laboratories
1
2012
21
0.030
 Why?
Hemizygote
1
2011
6
0.030
 Why?
Predictive Value of Tests
1
2014
904
0.030
 Why?
Drug Resistance, Neoplasm
1
2013
308
0.020
 Why?
Animals
2
2018
13150
0.020
 Why?
Bone Marrow
1
2013
362
0.020
 Why?
Breast Neoplasms
1
2020
1169
0.020
 Why?
Vincristine
1
2010
89
0.020
 Why?
Prednisolone
1
2010
55
0.020
 Why?
Adolescent
1
2021
6340
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
412
0.020
 Why?
Cluster Analysis
1
2010
235
0.020
 Why?
Precancerous Conditions
1
2010
83
0.020
 Why?
Cyclophosphamide
1
2010
165
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
142
0.020
 Why?
Clinical Trials as Topic
1
2012
460
0.020
 Why?
Stem Cell Transplantation
1
2010
181
0.020
 Why?
Child
1
2021
6824
0.020
 Why?
Doxorubicin
1
2010
230
0.020
 Why?
Sex Factors
1
2011
693
0.020
 Why?
Models, Biological
1
2012
728
0.020
 Why?
Up-Regulation
1
2010
450
0.020
 Why?
Risk Assessment
1
2013
1262
0.020
 Why?
Prevalence
1
2011
943
0.020
 Why?
Mice
1
2018
5720
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (260) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department